Chemotherapy: YES or NO?

The FEMTELLE® uPA/PAI-1 Test helps to make informed treatment decisions

The FEMTELLE® uPA/PAI-1 Assay is included in German and American guidelines. The test helps to assess risk of disease recurrence in primary breast cancer and predicts chemotherapy benefit after breast cancer surgery.

The  FEMTELLE® uPA/PAI-1 Assay indicates if chemotherapy is, in fact necessary and helps to predict chemotherapy benefit after surgery.

News

FEMTELLE Brochure

A new revised version of our FEMTELLE Brochure is now available. more...